Sugarloaf Wealth Management’s Fidelity MSCI Information Technology Index ETF FTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$10.9K Buy
+59
New +$10.8K ﹤0.01% 489
2023
Q4
Sell
-59
Closed -$7.25K 690
2023
Q3
$7.25K Hold
59
﹤0.01% 500
2023
Q2
$7.71K Hold
59
﹤0.01% 506
2023
Q1
$6.72K Hold
59
﹤0.01% 520
2022
Q4
$5.58K Hold
59
﹤0.01% 566
2022
Q3
$6K Hold
59
﹤0.01% 584
2022
Q2
$6K Hold
59
﹤0.01% 583
2022
Q1
$7K Hold
59
﹤0.01% 522
2021
Q4
$8K Hold
59
﹤0.01% 534
2021
Q3
$7K Hold
59
﹤0.01% 556
2021
Q2
$7K Buy
59
+49
+490% +$5.46K ﹤0.01% 555
2021
Q1
$6 Sell
10
-49
-83% -$5.21K ﹤0.01% 569
2020
Q4
$6K Hold
59
﹤0.01% 525
2020
Q3
$5K Buy
+59
New +$5.25K ﹤0.01% 516

Other funds holding FTEC

Sugarloaf Wealth Management's FTEC Position: Q4 2024 in Review

Sugarloaf Wealth Management opened a new position in Fidelity MSCI Information Technology Index ETF (FTEC) in Q4 2024: 59 shares worth $10.9K. The stake represents ﹤0.01% of the portfolio and ranks #489 among its holdings. This is a return to the name: Sugarloaf Wealth Management previously reported a position in FTEC as recently as Q3 2023.

Sugarloaf Wealth Management first reported a position in FTEC in Q3 2020 and has held it in 14 quarters since. 508 funds tracked by Wall St. Rank hold FTEC as of Q4 2024.

  • Sugarloaf Wealth Management held 59 shares of Fidelity MSCI Information Technology Index ETF worth $10.9K as of Q4 2024.
  • Fidelity MSCI Information Technology Index ETF was a new Sugarloaf Wealth Management position in Q4 2024.
  • Fidelity MSCI Information Technology Index ETF made up ﹤0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #489 holding.
  • Sugarloaf Wealth Management first reported a position in Fidelity MSCI Information Technology Index ETF in Q3 2020 and has held it in 14 quarters since.
  • 508 funds tracked by Wall St. Rank held Fidelity MSCI Information Technology Index ETF as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.